Lovastatin regulates brain spontaneous low-frequency brain activity in Neurofibromatosis type 1

Neuroscience Letters

Volumn 515, Issue 1, 2012, Pages 28-33

  Chabernaud, Camille ^a   Mennes, Maarten ^a   Kardel, Peter G ^b   Gaillard, William D ^b   Kalbfleisch, M Layne ^c   VanMeter, John W ^d   Packer, Roger J ^b   Milham, Michael P ^e,f   Castellanos, Francisco X ^a,f   Acosta, Maria T ^b  

^a NEW YORK UNIVERSITY CHILD STUDY CENTER   (United States)

^b CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^c GEORGE MASON UNIVERSITY   (United States)

^d GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^e CHILD MIND INSTITUTE   (United States)

^f NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

Author keywords

Children; Default network; Lovastatin; Neurofibromatosis type 1; Resting state fMRI

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CREATINE KINASE; CREATININE; GLUCOSE; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; MEVINOLIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADOLESCENT; ARTICLE; BLOOD CELL COUNT; BRAIN FUNCTION; CHILD; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; DEFAULT NETWORK; ECHO PLANAR IMAGING; ELECTROENCEPHALOGRAM; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; IMAGE PROCESSING; MALE; NEUROFIBROMATOSIS; PREFRONTAL CORTEX; PREGNANCY TEST; PRIORITY JOURNAL; REGULATORY MECHANISM; RESTING STATE FUNCTIONAL CONNECTIVITY; SCHOOL CHILD; TREATMENT DURATION; UREA NITROGEN BLOOD LEVEL; URINALYSIS;

ADOLESCENT; BRAIN; CHILD; FEMALE; HUMANS; LOVASTATIN; MAGNETIC RESONANCE IMAGING; MALE; NERVE NET; NEUROFIBROMATOSIS 1;

EID: 84859443351     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2012.03.009     Document Type: Article

References (32)

1. Acosta M.T., Gioia G.A., Silva A.J. Neurofibromatosis type 1: new insights into neurocognitive issues. Curr. Neurol. Neurosci. Rep. 2006, 6:136-143.
2. Acosta M.T., Kardel P.G., Walsh K.S., Rosenbaum K.N., Gioia G.A., Packer R.J. Lovastatin as treatment for neurocognitive deficits in neurofibromatosis type 1: phase I study. Pediatr. Neurol. 2011, 45:241-245.
3. Andrews-Hanna J.R., Reidler J.S., Huang C., Buckner R.L. Evidence for the default network's role in spontaneous cognition. J. Neurophysiol. 2010, 104:322-335.
4. Andrews-Hanna J.R., Reidler J.S., Sepulcre J., Poulin R., Buckner R.L. Functional-anatomic fractionation of the brain's default network. Neuron 2010, 65:550-562.
5. Ballester R., Marchuk D., Boguski M., Saulino A., Letcher R., Wigler M., Collins F. The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins. Cell 1990, 63:851-859.
6. Basser P.J., Jones D.K. Diffusion-tensor MRI: theory, experimental design and data analysis - a technical review. NMR Biomed. 2002, 15:456-467.
7. Billingsley R.L., Jackson E.F., Slopis J.M., Swank P.R., Mahankali S., Moore B.D. Functional magnetic resonance imaging of phonologic processing in neurofibromatosis 1. J. Child Neurol. 2003, 18:731-740.
8. Billingsley R.L., Jackson E.F., Slopis J.M., Swank P.R., Mahankali S., Moore B.D. Functional MRI of visual-spatial processing in neurofibromatosis, type 1. Neuropsychologia 2004, 42:395-404.
9. Cole D.M., Smith S.M., Beckmann C.F. Advances and pitfalls in the analysis and interpretation of resting-state FMRI data. Front. Syst. Neurosci. 2010, 4:8.
10. Costa R.M., Federov N.B., Kogan J.H., Murphy G.G., Stern J., Ohno M., Kucherlapati R., Jacks T., Silva A.J. Mechanism for the learning deficits in a mouse model of neurofibromatosis type 1. Nature 2002, 415:526-530.
11. Dasgupta B., Gutmann D.H. Neurofibromin regulates neural stem cell proliferation, survival, and astroglial differentiation in vitro and in vivo. J. Neurosci. 2005, 25:5584-5594.
12. Dosenbach N.U., Nardos B., Cohen A.L., Fair D.A., Power J.D., Church J.A., Nelson S.M., Wig G.S., Vogel A.C., Lessov-Schlaggar C.N., Barnes K.A., Dubis J.W., Feczko E., Coalson R.S., Pruett J.R., Barch D.M., Petersen S.E., Schlaggar B.L. Prediction of individual brain maturity using fMRI. Science 2010, 329:1358-1361.
13. Durston S., Davidson M.C., Tottenham N., Galvan A., Spicer J., Fossella J.A., Casey B.J. A shift from diffuse to focal cortical activity with development. Dev. Sci. 2006, 9:1-8.
14. Fair D.A., Cohen A.L., Dosenbach N.U., Church J.A., Miezin F.M., Barch D.M., Raichle M.E., Petersen S.E., Schlaggar B.L. The maturing architecture of the brain's default network. Proc. Natl. Acad. Sci. U.S.A. 2008, 105:4028-4032.
15. Fair D.A., Schlaggar B.L., Cohen A.L., Miezin F.M., Dosenbach N.U., Wenger K.K., Fox M.D., Snyder A.Z., Raichle M.E., Petersen S.E. A method for using blocked and event-related fMRI data to study resting state functional connectivity. Neuroimage 2007, 35:396-405.
16. Fransson P. How default is the default mode of brain function? Further evidence from intrinsic BOLD signal fluctuations. Neuropsychologia 2006, 44:2836-2845.
17. Greicius M.D., Supekar K., Menon V., Dougherty R.F. Resting-state functional connectivity reflects structural connectivity in the default mode network. Cereb. Cortex 2009, 19:72-78.
18. Hampson M., Driesen N.R., Skudlarski P., Gore J.C., Constable R.T. Brain connectivity related to working memory performance. J. Neurosci. 2006, 26:13338-13343.
19. Huson S.M., Compston D.A., Clark P., Harper P.S. A genetic study of von Recklinghausen neurofibromatosis in south east Wales. I. Prevalence, fitness, mutation rate, and effect of parental transmission on severity. J. Med. Genet. 1989, 26:704-711.
20. Hyman S.L., Shores A., North K.N. The nature and frequency of cognitive deficits in children with neurofibromatosis type 1. Neurology 2005, 65:1037-1044.
21. Kelly A.M., Di Martino A., Uddin L.Q., Shehzad Z., Gee D.G., Reiss P.T., Margulies D.S., Castellanos F.X., Milham M.P. Development of anterior cingulate functional connectivity from late childhood to early adulthood. Cereb. Cortex 2009, 19:640-657.
22. Klose A., Ahmadian M.R., Schuelke M., Scheffzek K., Hoffmeyer S., Gewies A., Schmitz F., Kaufmann D., Peters H., Wittinghofer A., Nurnberg P. Selective disactivation of neurofibromin GAP activity in neurofibromatosis type 1. Hum. Mol. Genet. 1998, 7:1261-1268.
23. Krab L.C., de Goede-Bolder A., Aarsen F.K., Pluijm S.M., Bouman M.J., van der Geest J.N., Lequin M., Catsman C.E., Arts W.F., Kushner S.A., Silva A.J., de Zeeuw C.I., Moll H.A., Elgersma Y. Effect of simvastatin on cognitive functioning in children with neurofibromatosis type 1: a randomized controlled trial. JAMA 2008, 300:287-294.
24. Li W., Cui Y., Kushner S.A., Brown R.A., Jentsch J.D., Frankland P.W., Cannon T.D., Silva A.J. The HMG-CoA reductase inhibitor lovastatin reverses the learning and attention deficits in a mouse model of neurofibromatosis type 1. Curr. Biol. 2005, 15:1961-1967.
25. Lush M.E., Li Y., Kwon C.H., Chen J., Parada L.F. Neurofibromin is required for barrel formation in the mouse somatosensory cortex. J. Neurosci. 2008, 28:1580-1587.
26. Power J.D., Barnes K.A., Snyder A.Z., Schlaggar B.L., Petersen S.E. Spurious but systematic correlations in functional connectivity MRI networks arise from subject motion. Neuroimage 2011.
27. Sebti S.M., Tkalcevic G.T., Jani J.P. Lovastatin, a cholesterol biosynthesis inhibitor, inhibits the growth of human H-ras oncogene transformed cells in nude mice. Cancer Commun. 1991, 3:141-147.
28. Shehzad Z., Kelly A.M., Reiss P.T., Gee D.G., Gotimer K., Uddin L.Q., Lee S.H., Margulies D.S., Roy A.K., Biswal B.B., Petkova E., Castellanos F.X., Milham M.P. The resting brain: unconstrained yet reliable. Cereb. Cortex 2009, 19:2209-2229.
29. Smith S.M., Fox P.T., Miller K.L., Glahn D.C., Fox P.M., Mackay C.E., Filippini N., Watkins K.E., Toro R., Laird A.R., Beckmann C.F. Correspondence of the brain's functional architecture during activation and rest. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:13040-13045.
30. Tomasi D., Ernst T., Caparelli E.C., Chang L. Common deactivation patterns during working memory and visual attention tasks: an intra-subject fMRI study at 4Tesla. Hum. Brain Mapp. 2006, 27:694-705.
31. Van Dijk K.R.A., Sabuncu M.R., Buckner R.L. The influence of head motion on intrinsic functional connectivity MRI. Neuroimage 2012, 59:431-438.
32. van Engelen S.J., Krab L.C., Moll H.A., de Goede-Bolder A., Pluijm S.M., Catsman-Berrevoets C.E., Elgersma Y., Lequin M.H. Quantitative differentiation between healthy and disordered brain matter in patients with neurofibromatosis type I using diffusion tensor imaging. AJNR Am. J. Neuroradiol. 2008, 29:816-822.